Medicare Enrolled

Dr. Leonardo Forero, MD

Hematology & Oncology · Amarillo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1000 S COULTER ST, Amarillo, TX 79106
8063588654
In practice since 2006 (20 years)
NPI: 1700847464 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Forero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Forero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Forero

Dr. Leonardo Forero is a hematology & oncology in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Forero performed 205,722 Medicare services across 3,557 unique beneficiaries.

Between the years covered by Open Payments, Dr. Forero received a total of $18,177 from 34 pharmaceutical and/or device companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Forero is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in TX$ $18,177 industry payments

Medicare Practice Summary

Medicare Utilization ↗
205,722
Medicare services
Top 1% in TX for hematology & oncology
3,557
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,286 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)48,000$1$4
Iron infusion (Feraheme)26,520$0$5
Filgrastim injection (Nivestym) for white blood cells23,520$0$2
Paclitaxel chemotherapy injection14,890$0$8
Filgrastim injection (Zarxio) for white blood cells14,700$0$2
Contrast dye for imaging (iodine-based)12,801$0$3
Oxaliplatin chemotherapy injection12,423$0$33
Pembrolizumab injection (Keytruda)11,700$43$137
Darbepoetin injection (Aranesp) for anemia10,150$2$20
Denosumab injection (Prolia/Xgeva)7,440$18$66
Dexamethasone injection (steroid)3,327$0$1
Daratumumab injection (Darzalex)3,060$38$127
Immune globulin infusion (Octagam)2,730$33$233
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg1,440$21$181
Injection, granisetron hydrochloride, 100 mcg1,260$0$24
Anti-nausea injection (Aloxi/palonosetron)1,000$1$114
Injection, leucovorin calcium, per 50 mg843$3$25
Epoetin alfa injection (Retacrit) for anemia823$6$28
Injection, magnesium sulfate, per 500 mg820$1$6
Injection, carboplatin, 50 mg578$2$300
Injection, fluorouracil, 500 mg511$2$13
Administration of chemotherapy into vein, 1 hour or less463$97$707
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less441$22$157
Blood draw (venipuncture)400$8$20
Drug injection, under skin or into muscle390$10$96
Complete blood count (CBC) with differential387$8$36
Injection, potassium chloride, per 2 meq370$0$1
Injection of additional new drug or substance into vein369$12$108
Injection, zoledronic acid, 1 mg360$7$431
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less334$48$313
Office visit, established patient (30-39 min)319$90$368
Comprehensive metabolic blood panel299$10$64
Administration of chemotherapy into vein, each additional hour242$21$161
Basic metabolic blood panel210$8$49
Office visit, established patient (20-29 min)188$59$250
Administration of additional new drug or substance into vein, 1 hour or less172$48$344
Injection, diphenhydramine hcl, up to 50 mg166$1$7
Infusion, normal saline solution , 1000 cc153$2$19
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle135$54$211
Unclassified drugs120$1$9
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour115$16$100
Ct scan of chest with contrast111$53$821
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg94$348$1,722
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle85$25$145
Bilirubin level, total83$5$23
Phosphatase (enzyme) level, alkaline83$5$27
Total protein level, blood83$4$42
Liver enzyme (sgot), level83$5$33
Liver enzyme (sgpt), level83$5$28
Infusion, normal saline solution, sterile (500 ml = 1 unit)75$1$19
CT scan of abdomen and pelvis with contrast73$166$1,067
Infusion into a vein for hydration, 31-60 minutes73$23$256
Infusion into a vein for hydration, each additional hour73$10$75
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion73$15$94
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l67$123$500
Irrigation of implanted venous access drug delivery device62$15$114
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg47$1$17
Administration of chemotherapy into vein using push technique40$74$500
Office visit, established patient, complex (40-54 min)33$133$496
Administration of additional new drug or substance into vein using push technique28$40$289
Flu vaccine administration25$30$58
Flu vaccine, quadrivalent24$76$171
Injection of drug or substance into vein24$27$247
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries24$91$657
Nuclear medicine study from skull base to mid-thigh with ct scan21$1,109$4,802
CT scan of chest, without contrast20$51$686
Ct scan of soft tissue of neck with contrast16$74$658
Injection, methylprednisolone sodium succinate, up to 125 mg15$4$25
New patient office visit (30-44 min)13$77$372
New patient office visit (45-59 min)11$102$565
New patient office visit, complex (60-74 min)11$137$709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
38.2% high complexity
60.4% medium
1.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,177
Total received (2018-2024)
Avg $2,597/year across 7 years
Top 22% in TX for hematology & oncology
34
Companies
109
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,039 (60.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,937 (21.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,200 (17.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$638
2023
$274
2022
$655
2021
$179
2020
$34
2019
$9,456
2018
$6,941

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$8,393
Merck Sharp & Dohme Corporation
$5,894
Foundation Medicine, Inc.
$1,355
Astellas Pharma US Inc
$402
PFIZER INC.
$323
Seattle Genetics, Inc.
$209
Sirtex Medical Inc
$189
Janssen Scientific Affairs, LLC
$179
AstraZeneca Pharmaceuticals LP
$162
Novartis Pharmaceuticals Corporation
$145
Janssen Biotech, Inc.
$122
Seagen Inc.
$110
Daiichi Sankyo Inc.
$90
Novocure Inc.
$76
Lilly USA, LLC
$72
GENZYME CORPORATION
$62
Abbott Laboratories
$48
PUMA BIOTECHNOLOGY, INC.
$38
Karyopharm Therapeutics Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$30
Amgen Inc.
$27
Puma Biotechnology, Inc.
$26
Myovant Sciences Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$21
Exelixis Inc.
$20
ImmunoGen, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Genentech USA, Inc.
$16
Celgene Corporation
$16
JAZZ PHARMACEUTICALS INC.
$14
Tactile Systems Technology Inc
$13
Gilead Sciences, Inc.
$12
TESARO, Inc.
$11
Clovis Oncology, Inc.
$7
Top 3 companies account for 86.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · BALVERSA · Cabometyx · DARZALEX · EMPLICITI · ERLEADA · Elahere · Enhertu · Erleada · FOUNDATIONACT · FOUNDATIONONE · Flexitouch Plus · IBRANCE · IMFINZI · Imbruvica · KEYTRUDA · KISQALI · KYMRIAH · LIBTAYO · LUTATHERA · MEKINIST · NERLYNX · Nerlynx · OPDIVO · ORGOVYX · Oncology · PADCEV · PIQRAY · PROCLAIM · Prolia · Rubraca · SARCLISA · SIR-Spheres Microspheres · SUTENT · TAGRISSO · TECENTRIQ · TUKYSA · VERZENIO · Vitrakvi · XGEVA · XPOVIO · XTANDI · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (61%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $9 per 100 Medicare services performed
Looking for a hematology & oncology in Amarillo?
Compare hematology & oncologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
10
Per 100K population
8.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Forero is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and speaking/promotional industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Forero experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Forero performed 48,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Forero receive payments from pharmaceutical companies?
Yes. Dr. Forero received a total of $18,177 from 34 companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Forero's costs compare to other hematology & oncologys in Amarillo?
Dr. Forero's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Forero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →